Based on our prognostic model predicting recurrence and survival, patients exhibiting low expression levels of TIGIT and NKG2A demonstrated favorable prognoses, indicating a negative correlation between their expression and HCC prognosis. The gene discussed is TIGIT; the disease is hepatocellular carcinoma.